Thermo Fisher Scientific Inc(TMO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 13 at 6:27 PM ET (Korea 11/14 08:27)AI-drawn chart patterns are for reference only.
Full metrics table
| Index | S&P 500, RUI | P/E | 36.94 | EPS (ttm) | 18.95 | Insider Own | 0.26% | Shs Outstand | 370.5M | Perf Week | 0.79% |
| Market Cap | 259.44B | Forward P/E | 25.24 | EPS next Y | 9.71% | Insider Trans | -9.89% | Shs Float | 369.6M | Perf Month | 0.54% |
| Enterprise Value | 294.88B | PEG | 2.47 | EPS next Q | 7.13 | Inst Own | 95.73% | Short Float | 1.29% | Perf Quarter | 19.59% |
| Income | 7.07B | P/S | 5.48 | EPS this Y | 10.58% | Inst Trans | -0.61% | Short Ratio | 2.25 | Perf Half Y | 59.74% |
| Sales | 47.35B | P/B | 4.74 | EPS next 5Y | 10.2% | ROA | 6.51% | Short Interest | 4.78M | Perf YTD | 20.84% |
| Book/sh | 147.8 | P/C | 42.73 | EPS past 3/5Y | 0.18% 2.11% | ROE | 13.38% | 52W High | -3.76% ($727.56) | Perf Year | 20.7% |
| Cash/sh | 16.39 | P/FCF | 34.16 | Sales past 3/5Y | -0.27% 6.7% | ROIC | 7.54% | 52W Low | 60.87% ($435.27) | Perf 3Y | 57.3% |
| Dividend Est. | $1.86 (0.27%) | EV/EBITDA | 24.26 | EPS Y/Y TTM | 9.59% | Gross Margin | 40.49% | Volatility(W/M) | 2.31% 3.11% | Perf 5Y | 10.23% |
| Dividend TTM | 1.84 | EV/Sales | 6.23 | Sales Y/Y TTM | 8.27% | Oper. Margin | 19.11% | ATR (14) | 20.64 | Perf 10Y | 362.96% |
| Dividend Ex-Date | 2026/12/15 | Quick Ratio | 1.41 | EPS Q/Q | 8.51% | Profit Margin | 14.94% | RSI (14) | 53.69 | Recom | 1.52 |
| Dividend Gr. 3/5Y | 12.75% 14.34% | Current Ratio | 1.81 | Sales Q/Q | 9.13% | SMA20 | 0.64% ($695.77) | Beta | 0.85 | Target Price | $766.12 |
| Payout | 9.7% | Debt/Eq | 0.76 | Earnings | 2026/10/21 | SMA50 | 4.41% ($670.64) | Rel Volume | 0.86 | Prev Close | $699.44 |
| Employees | 125000 | LT Debt/Eq | 0.71 | EPS/Sales Surpr. | 4.32% 1.54% | SMA200 | 26.08% ($555.38) | Avg Volume(3M) | 2.13M | Price | $700.22 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 33266 | Volume | 1,837,483 | Change | 0.11% |
🔬 Thermo Fisher Scientific is a global leader in science solutions, supplying a broad range of products for life sciences research, diagnostics, bioprocessing, analytical instruments, and laboratory consumables. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company is headquartered in Waltham, Massachusetts, and is distinguished by its extensive product catalog and global distribution network.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded about as much as usual. That is 86% of its average volume.
TMO makes money exceptionally well
Of every $100 in sales, $19.11 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.6% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $2,426. Peers typically go for $2,426. Compared with its own 5-year average, it is 15% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +10.2%. The S&P 500 did +61% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.27% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 95.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It is the largest in the industry
Based on market cap of $259B.
TMO#1 Thermo Fisher Scientific Inc $259B PER 36.9 
DHR#2 Danaher Corp $164B PER 38.1 
IDXX#3 Idexx Laboratories Inc $55B PER 47.5 
A#4 Agilent Technologies Inc $49B PER 34.3 
NTRA#5 Natera Inc $46B PER - 
FAQ
What kind of company is TMO?
TMO belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of TMO?
The market cap of TMO is approximately $259.4B, ranking 54 within its sector.
Does TMO pay dividends?
TMO has a dividend yield of approximately 0.27%, with an annual dividend of $1.86.
What is the P/E ratio of TMO?
TMO has a P/E ratio of approximately 36.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for TMO?
TMO has recorded a 52-week high of $727.56 and a low of $435.27.
